{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:49:59Z","timestamp":1791298199637,"version":"4.1.0"},"reference-count":176,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00204-025-04088-y","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T12:28:53Z","timestamp":1748953733000},"page":"3527-3552","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["An update on the involvement of inflammatory mediators in Parkinson\u2019s disease pathogenesis"],"prefix":"10.1007","volume":"99","author":[{"given":"Oyashvi","family":"Verma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Faizan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1198-6381","authenticated-orcid":false,"given":"Mahendra Pratap","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"key":"4088_CR1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.neulet.2017.09.032","volume":"660","author":"A Abbaoui","year":"2017","unstructured":"Abbaoui A, Chatoui H, El Hiba O, Gamrani H (2017a) Neuroprotective effect of curcumin-I in copper-induced dopaminergic neurotoxicity in rats: a possible link with Parkinson\u2019s disease. Neurosci Lett 660:103\u2013108. https:\/\/doi.org\/10.1016\/j.neulet.2017.09.032","journal-title":"Neurosci Lett"},{"key":"4088_CR2","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.acthis.2017.06.003","volume":"119","author":"A Abbaoui","year":"2017","unstructured":"Abbaoui A, Hiba OE, Gamrani H (2017b) Neuroprotective potential of Aloe arborescens against copper induced neurobehavioral features of Parkinson\u2019s disease in rat. Acta Histochem 119:592\u2013601. https:\/\/doi.org\/10.1016\/j.acthis.2017.06.003","journal-title":"Acta Histochem"},{"key":"4088_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113330","volume":"153","author":"K Abu-Elfotuh","year":"2022","unstructured":"Abu-Elfotuh K, Hamdan AME, Abbas AN, Alahmre ATS, Elewa MAF, Masoud RAE, Ali AA, Othman M, Kamal MM, Hassan FAM, Khalil MG, El Sisi AM, Abdel Hady MMM, Abd-Elhaleim El Azazy MK, Awny MM, Wahid A (2022a) Evaluating the neuroprotective activities of vinpocetine, punicalagin, niacin and vitamin E against behavioural and motor disabilities of manganese-induced Parkinson\u2019s disease in Sprague dawley rats. Biomed Pharmacother 153:113330. https:\/\/doi.org\/10.1016\/j.biopha.2022.113330","journal-title":"Biomed Pharmacother"},{"key":"4088_CR4","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.3390\/ph15121554","volume":"15","author":"K Abu-Elfotuh","year":"2022","unstructured":"Abu-Elfotuh K, Hamdan AME, Mohammed AA, Atwa AM, Kozman MR, Ibrahim AM, Motawea SM, Selim HMRM, Tohamy STK, Nour El-Din M, Zaghlool SS, Gowifel AMH, Awny MM (2022b) Neuroprotective effects of some nutraceuticals against manganese-induced Parkinson\u2019s disease in rats: possible modulatory effects on TLR4\/NLRP3\/NF-\u03baB, GSK-3\u03b2, Nrf2\/HO-1, and apoptotic pathways. Pharmaceuticals (Basel) 15:1554. https:\/\/doi.org\/10.3390\/ph15121554","journal-title":"Pharmaceuticals (Basel)"},{"key":"4088_CR5","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1080\/10715760802513733","volume":"42","author":"I Ahmad","year":"2008","unstructured":"Ahmad I, Kumar A, Shukla S, Prasad Pandey H, Singh C (2008) The involvement of nitric oxide in Maneb- and Paraquat-induced oxidative stress in rat polymorphonuclear leukocytes. Free Radic Res 42:849\u2013862. https:\/\/doi.org\/10.1080\/10715760802513733","journal-title":"Free Radic Res"},{"key":"4088_CR6","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1038\/s41380-022-01910-2","volume":"28","author":"EH Ahn","year":"2023","unstructured":"Ahn EH, Liu X, Alam AM, Kang SS, Ye K (2023) Helicobacter hepaticus augmentation triggers dopaminergic degeneration and motor disorders in mice with Parkinson\u2019s disease. Mol Psychiatry 28:1337\u20131350. https:\/\/doi.org\/10.1038\/s41380-022-01910-2","journal-title":"Mol Psychiatry"},{"key":"4088_CR7","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.brainresbull.2005.07.012","volume":"67","author":"A Ajjimaporn","year":"2005","unstructured":"Ajjimaporn A, Swinscoe J, Shavali S, Govitrapong P, Ebadi M (2005) Metallothionein provides zinc-mediated protective effects against methamphetamine toxicity in SK-N-SH cells. Brain Res Bull 67:466\u2013475. https:\/\/doi.org\/10.1016\/j.brainresbull.2005.07.012","journal-title":"Brain Res Bull"},{"key":"4088_CR8","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.3233\/JPD-223423","volume":"12","author":"ZAM Al-Azzawi","year":"2022","unstructured":"Al-Azzawi ZAM, Arfaie S, Gan-Or Z (2022) GBA1 and the immune system: a potential role in Parkinson\u2019s disease? J Parkinsons Dis 12:S53\u2013S64. https:\/\/doi.org\/10.3233\/JPD-223423","journal-title":"J Parkinsons Dis"},{"key":"4088_CR9","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1073\/pnas.0914876107","volume":"107","author":"H Aleyasin","year":"2010","unstructured":"Aleyasin H, Rousseaux MW, Marcogliese PC, Hewitt SJ, Irrcher I, Joselin AP, Parsanejad M, Kim RH, Rizzu P, Callaghan SM, Slack RS, Mak TW, Park DS (2010) DJ-1 protects the nigrostriatal axis from the neurotoxin MPTP by modulation of the AKT pathway. Proc Natl Acad Sci USA 107:3186\u20133191. https:\/\/doi.org\/10.1073\/pnas.0914876107","journal-title":"Proc Natl Acad Sci USA"},{"key":"4088_CR10","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00335-011-9330-x","volume":"22","author":"PM Antony","year":"2011","unstructured":"Antony PM, Diederich NJ, Balling R (2011) Parkinson\u2019s disease mouse models in translational research. Mamm Genome 22:401\u2013419. https:\/\/doi.org\/10.1007\/s00335-011-9330-x","journal-title":"Mamm Genome"},{"key":"4088_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4196\/kjpp.2014.18.2.129","volume":"18","author":"B Aryal","year":"2014","unstructured":"Aryal B, Lee JK, Kim HR, Kim HG (2014) Alteration of striatal tetrahydrobiopterin in iron-induced unilateral model of Parkinson\u2019s disease. Korean J Physiol Pharmacol 18:129\u2013134. https:\/\/doi.org\/10.4196\/kjpp.2014.18.2.129","journal-title":"Korean J Physiol Pharmacol"},{"key":"4088_CR12","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.parkreldis.2005.07.005","volume":"11","author":"Y Baba","year":"2005","unstructured":"Baba Y, Kuroiwa A, Uitti RJ, Wszolek ZK, Yamada T (2005) Alterations of T-lymphocyte populations in Parkinson disease. Parkinsonism Relat Disord 11:493\u2013498. https:\/\/doi.org\/10.1016\/j.parkreldis.2005.07.005","journal-title":"Parkinsonism Relat Disord"},{"key":"4088_CR13","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3389\/fneur.2019.00218","volume":"10","author":"N Ball","year":"2019","unstructured":"Ball N, Teo WP, Chandra S, Chapman J (2019) Parkinson\u2019s disease and the environment. Front Neurol 10:218. https:\/\/doi.org\/10.3389\/fneur.2019.00218","journal-title":"Front Neurol"},{"key":"4088_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105744","volume":"170","author":"M Bartl","year":"2022","unstructured":"Bartl M, Xylaki M, B\u00e4hr M, Weber S, Trenkwalder C, Mollenhauer B (2022) Evidence for immune system alterations in peripheral biological fluids in Parkinson\u2019s disease. Neurobiol Dis 170:105744. https:\/\/doi.org\/10.1016\/j.nbd.2022.105744","journal-title":"Neurobiol Dis"},{"key":"4088_CR15","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.3390\/ijms26062440","volume":"26","author":"AI Beltran-Velasco","year":"2025","unstructured":"Beltran-Velasco AI, Clemente-Su\u00e1rez VJ (2025) Impact of peripheral inflammation on blood\u2013brain Barrier dysfunction and its role in neurodegenerative diseases. Int J Mol Sci 26:2440. https:\/\/doi.org\/10.3390\/ijms26062440","journal-title":"Int J Mol Sci"},{"key":"4088_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001376","volume":"3","author":"EJ Benner","year":"2008","unstructured":"Benner EJ, Banerjee R, Reynolds AD, Sherman S, Pisarev VM, Tsiperson V, Nemachek C, Ciborowski P, Przedborski S, Mosley RL, Gendelman HE (2008) Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons. PLoS ONE 3:e1376. https:\/\/doi.org\/10.1371\/journal.pone.0001376","journal-title":"PLoS ONE"},{"key":"4088_CR17","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.1002\/ana.410320718","volume":"32","author":"D Ben-Shachar","year":"1992","unstructured":"Ben-Shachar D, Eshel G, Riederer P, Youdim MB (1992) Role of iron and iron chelation in dopaminergic-induced neurodegeneration: implication for Parkinson\u2019s disease. Ann Neurol 32:S105\u2013S110. https:\/\/doi.org\/10.1002\/ana.410320718","journal-title":"Ann Neurol"},{"key":"4088_CR18","doi-asserted-by":"publisher","first-page":"11328","DOI":"10.3390\/ijms222111328","volume":"22","author":"H Berlamont","year":"2021","unstructured":"Berlamont H, Bruggeman A, Bauwens E, Vandendriessche C, Clarebout E, Xie J, De Bruyckere S, Van Imschoot G, Van Wonterghem E, Ducatelle R, Santens P, Smet A, Haesebrouck F, Vandenbroucke RE (2021) Gastric Helicobacter suis infection partially protects against neurotoxicity in a 6-OHDA Parkinson\u2019s disease mouse model. Int J Mol Sci 22:11328. https:\/\/doi.org\/10.3390\/ijms222111328","journal-title":"Int J Mol Sci"},{"key":"4088_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039953","volume":"7","author":"M Bian","year":"2012","unstructured":"Bian M, Liu J, Hong X, Yu M, Huang Y, Sheng Z, Fei J, Huang F (2012) Overexpression of parkin ameliorates dopaminergic neurodegeneration induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. PLoS ONE 7:e39953. https:\/\/doi.org\/10.1371\/journal.pone.0039953","journal-title":"PLoS ONE"},{"key":"4088_CR20","doi-asserted-by":"publisher","first-page":"22809","DOI":"10.1074\/jbc.M113.482091","volume":"288","author":"B Bj\u00f6rkblom","year":"2013","unstructured":"Bj\u00f6rkblom B, Adilbayeva A, Maple-Gr\u00f8dem J, Piston D, \u00d6kvist M, Xu XM, Brede C, Larsen JP, M\u00f8ller SG (2013) Parkinson disease protein DJ-1 binds metals and protects against metal-induced cytotoxicity. J Biol Chem 288:22809\u201322820. https:\/\/doi.org\/10.1074\/jbc.M113.482091","journal-title":"J Biol Chem"},{"key":"4088_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0223238","volume":"14","author":"L Bordoni","year":"2019","unstructured":"Bordoni L, Gabbianelli R, Fedeli D, Fiorini D, Bergheim I, Jin CJ, Marinelli L, Di Stefano A, Nasuti C (2019) Positive effect of an electrolyzed reduced water on gut permeability, fecal microbiota and liver in an animal model of Parkinson\u2019s disease. PLoS One 14:e0223238. https:\/\/doi.org\/10.1371\/journal.pone.0223238","journal-title":"PLoS One"},{"key":"4088_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/09727531221117634","volume":"30","author":"S Bose","year":"2023","unstructured":"Bose S, Nag TC, Dey S, Sundd M, Jain S (2023) Therapeutic potential of low-intensity magnetic field stimulation in 6-hydroxydopamine rat model of Parkinson\u2019s disease: from inflammation to motor function. Ann Neurosci 30:11\u201319. https:\/\/doi.org\/10.1177\/09727531221117634","journal-title":"Ann Neurosci"},{"key":"4088_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","volume":"396","author":"H Braak","year":"2006","unstructured":"Braak H, de Vos RA, Bohl J, Del Tredici K (2006) Gastric alpha-synuclein immunoreactive inclusions in meissner\u2019s and auerbach\u2019s plexuses in cases staged for Parkinson\u2019s disease-related brain pathology. Neurosci Lett 396:67\u201372. https:\/\/doi.org\/10.1016\/j.neulet.2005.11.012","journal-title":"Neurosci Lett"},{"key":"4088_CR24","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1186\/s12864-015-2058-3","volume":"16","author":"R Calligaris","year":"2015","unstructured":"Calligaris R, Banica M, Roncaglia P, Robotti E, Finaurini S, Vlachouli C, Antonutti L, Iorio F, Carissimo A, Cattaruzza T, Ceiner A, Lazarevic D, Cucca A, Pangher N, Marengo E, di BernardoD PG, Gustincich S (2015) Blood transcriptomics of drug-na\u00efve sporadic Parkinson\u2019s disease patients. BMC Genom 16:876. https:\/\/doi.org\/10.1186\/s12864-015-2058-3","journal-title":"BMC Genom"},{"key":"4088_CR25","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1111\/j.1460-9568.2005.04281.x","volume":"22","author":"PM Carvey","year":"2005","unstructured":"Carvey PM, Zhao CH, Hendey B, Lum H, Trachtenberg J, Desai BS, Snyder J, Zhu YG, Ling ZD (2005) 6-Hydroxydopamine-induced alterations in blood\u2013brain barrier permeability. Eur J Neurosci 22:1158\u20131168. https:\/\/doi.org\/10.1111\/j.1460-9568.2005.04281.x","journal-title":"Eur J Neurosci"},{"key":"4088_CR26","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.3233\/JPD-223461","volume":"12","author":"DG Chan","year":"2022","unstructured":"Chan DG, Ventura K, Villeneuve A, Du Bois P, Holahan MR (2022) Exploring the connection between the gut microbiome and Parkinson\u2019s disease symptom progression and pathology: implications for supplementary treatment options. J Parkinsons Dis 12:2339\u20132352. https:\/\/doi.org\/10.3233\/JPD-223461","journal-title":"J Parkinsons Dis"},{"key":"4088_CR27","doi-asserted-by":"publisher","first-page":"7095","DOI":"10.3390\/ijms24087095","volume":"24","author":"KH Chang","year":"2023","unstructured":"Chang KH, Liu CH, Wang YR, Lo YS, Chang CW, Wu HC, Chen CM (2023) Upregulation of APAF1 and CSF1R in peripheral blood mononuclear cells of Parkinson\u2019s disease. Int J Mol Sci 24:7095. https:\/\/doi.org\/10.3390\/ijms24087095","journal-title":"Int J Mol Sci"},{"key":"4088_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/308654","volume":"2014","author":"Y Chao","year":"2014","unstructured":"Chao Y, Wong SC, Tan EK (2014) Evidence of inflammatory system involvement in Parkinson\u2019s disease. Biomed Res 2014:308654. https:\/\/doi.org\/10.1155\/2014\/308654","journal-title":"Biomed Res"},{"key":"4088_CR29","doi-asserted-by":"publisher","first-page":"5782","DOI":"10.1007\/s12035-015-9478-6","volume":"53","author":"AK Chauhan","year":"2016","unstructured":"Chauhan AK, Mittra N, Kumar V, Patel DK, Singh C (2016) Inflammation and B-cell lymphoma-2 associated X protein regulate zinc-induced apoptotic degeneration of rat nigrostriatal dopaminergic neurons. Mol Neurobiol 53:5782\u20135795. https:\/\/doi.org\/10.1007\/s12035-015-9478-6","journal-title":"Mol Neurobiol"},{"key":"4088_CR30","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.3390\/nu13062099","volume":"13","author":"Y Chen","year":"2021","unstructured":"Chen Y, Xu J, Chen Y (2021) Regulation of neurotransmitters by the gut microbiota and effects on cognition in neurological disorders. Nutrients 13:2099. https:\/\/doi.org\/10.3390\/nu13062099","journal-title":"Nutrients"},{"key":"4088_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.947927","volume":"16","author":"Y Chen","year":"2022","unstructured":"Chen Y, Yin Q, Cheng XY, Zhang JR, Jin H, Li K, Mao CJ, Wang F, Bei HZ, Liu CF (2022) G2019S LRRK2 Mutation enhances MPP+-induced inflammation of human induced pluripotent stem cells-differentiated dopaminergic neurons. Front Neurosci 16:947927. https:\/\/doi.org\/10.3389\/fnins.2022.947927","journal-title":"Front Neurosci"},{"key":"4088_CR32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.toxlet.2023.09.004","volume":"387","author":"J Chen","year":"2023","unstructured":"Chen J, Gao X, Zheng C, Zhang C, Li P, He K, Liu G, Huang X, Liu J, Xie Y, Yang X (2023) Low-dose Cu exposure enhanced \u03b1-synuclein accumulation associates with mitochondrial impairments in mice model of Parkinson\u2019s disease. Toxicol Lett 387:14\u201327. https:\/\/doi.org\/10.1016\/j.toxlet.2023.09.004","journal-title":"Toxicol Lett"},{"key":"4088_CR33","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1007\/s12035-022-02758-x","volume":"59","author":"YY Cheng","year":"2022","unstructured":"Cheng YY, Chen BY, Bian GL, Ding YX, Chen LW (2022) Programmed death-1 deficiency aggravates motor dysfunction in MPTP model of Parkinson\u2019s disease by inducing microglial activation and neuroinflammation in mice. Mol Neurobiol 59:2642\u20132655. https:\/\/doi.org\/10.1007\/s12035-022-02758-x","journal-title":"Mol Neurobiol"},{"key":"4088_CR34","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.3390\/ijms21072464","volume":"21","author":"SJ Chia","year":"2020","unstructured":"Chia SJ, Tan EK, Chao YX (2020) Historical perspective: models of Parkinson\u2019s disease. Int J Mol Sci 21:2464. https:\/\/doi.org\/10.3390\/ijms21072464","journal-title":"Int J Mol Sci"},{"key":"4088_CR35","doi-asserted-by":"publisher","first-page":"5877","DOI":"10.1523\/JNEUROSCI.23-13-05877.2003","volume":"23","author":"SH Choi","year":"2003","unstructured":"Choi SH, Joe EH, Kim SU, Jin BK (2003) Thrombin-induced microglial activation produces degeneration of nigral dopaminergic neurons in vivo. J Neurosci 23:5877\u20135886. https:\/\/doi.org\/10.1523\/JNEUROSCI.23-13-05877.2003","journal-title":"J Neurosci"},{"key":"4088_CR36","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.nbd.2019.04.003","volume":"127","author":"DJ Choi","year":"2019","unstructured":"Choi DJ, An J, Jou I, Park SM, Joe EH (2019) A Parkinson\u2019s disease gene, DJ-1, regulates anti-inflammatory roles of astrocytes through prostaglandin D2 synthase expression. Neurobiol Dis 127:482\u2013491. https:\/\/doi.org\/10.1016\/j.nbd.2019.04.003","journal-title":"Neurobiol Dis"},{"key":"4088_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065352","volume":"8","author":"A Ciaramella","year":"2013","unstructured":"Ciaramella A, Salani F, Bizzoni F, Pontieri FE, Stefani A, Pierantozzi M, Assogna F, Caltagirone C, Spalletta G, Boss\u00f9 P (2013) Blood dendritic cell frequency declines in idiopathic Parkinson\u2019s disease and is associated with motor symptom severity. PLoS ONE 8:e65352. https:\/\/doi.org\/10.1371\/journal.pone.0065352","journal-title":"PLoS ONE"},{"key":"4088_CR38","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00018-020-03656-y","volume":"78","author":"A Ciesielska","year":"2021","unstructured":"Ciesielska A, Matyjek M, Kwiatkowska K (2021) TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling. Cell Mol Life Sci 78:1233\u20131261. https:\/\/doi.org\/10.1007\/s00018-020-03656-y","journal-title":"Cell Mol Life Sci"},{"key":"4088_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41531-017-0010-8","volume":"3","author":"DA Cook","year":"2017","unstructured":"Cook DA, Kannarkat GT, Cintron AF, Butkovich LM, Fraser KB, ChangJ GN, Factor SA, West AB, Boss JM, Tansey MG (2017) LRRK2 levels in immune cells are increased in Parkinson\u2019s disease. NPJ Parkinsons Dis 3:11. https:\/\/doi.org\/10.1038\/s41531-017-0010-8","journal-title":"NPJ Parkinsons Dis"},{"key":"4088_CR40","doi-asserted-by":"publisher","first-page":"13488","DOI":"10.3390\/ijms222413488","volume":"22","author":"L Cuenca-Bermejo","year":"2021","unstructured":"Cuenca-Bermejo L, Almela P, Navarro-Zaragoza J, Fern\u00e1ndez Villalba E, Gonz\u00e1lez-Cuello AM, Laorden ML, Herrero MT (2021) Cardiac changes in Parkinson\u2019s disease: lessons from clinical and experimental evidence. Int J Mol Sci 22:13488. https:\/\/doi.org\/10.3390\/ijms222413488","journal-title":"Int J Mol Sci"},{"key":"4088_CR41","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11481-021-10047-y","volume":"18","author":"C Cui","year":"2023","unstructured":"Cui C, Hong H, Shi Y, Zhou Y, Qiao CM, Zhao WJ, Zhao LP, Wu J, Quan W, Niu GY, Wu YB, Li CS, Cheng L, Hong Y, Shen YQ (2023) Vancomycin pretreatment on MPTP-induced Parkinson\u2019s disease mice exerts neuroprotection by suppressing inflammation both in brain and gut. J Neuroimmune Pharmacol 18:72\u201389. https:\/\/doi.org\/10.1007\/s11481-021-10047-y","journal-title":"J Neuroimmune Pharmacol"},{"key":"4088_CR42","doi-asserted-by":"publisher","first-page":"484","DOI":"10.2174\/1871527316666170223161004","volume":"16","author":"CC de Farias","year":"2017","unstructured":"de Farias CC, Maes M, Bonifacio KL, Matsumoto AK, Bortolasci CC, Nogueira AS, Brinholi FF, Morimoto HK, de Melo LB, Moreira EG, Barbosa DS (2017) Parkinson\u2019s disease is accompanied by intertwined alterations in iron metabolism and activated immune-inflammatory and oxidative stress pathways. CNS Neurol Disord Drug Targets 16:484\u2013491. https:\/\/doi.org\/10.2174\/1871527316666170223161004","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"4088_CR43","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1007\/s00018-013-1352-y","volume":"70","author":"M Deleidi","year":"2013","unstructured":"Deleidi M, Gasser T (2013) The role of inflammation in sporadic and familial Parkinson\u2019s disease. Cell Mol Life Sci 70:4259\u20134273. https:\/\/doi.org\/10.1007\/s00018-013-1352-y","journal-title":"Cell Mol Life Sci"},{"key":"4088_CR44","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1089\/jir.2008.0027","volume":"29","author":"SL Deshmane","year":"2009","unstructured":"Deshmane SL, Kremlev S, Amini S, Sawaya BE (2009) Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 29:313\u2013326. https:\/\/doi.org\/10.1089\/jir.2008.0027","journal-title":"J Interferon Cytokine Res"},{"key":"4088_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2020.152437","volume":"436","author":"W Ding","year":"2020","unstructured":"Ding W, Lin H, Hong X, Ji D, Wu F (2020) Poloxamer 188-mediated anti-inflammatory effect rescues cognitive deficits in paraquat and maneb-induced mouse model of Parkinson\u2019s disease. Toxicology 436:152437. https:\/\/doi.org\/10.1016\/j.tox.2020.152437","journal-title":"Toxicology"},{"key":"4088_CR46","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12974-018-1302-6","volume":"15","author":"RH Du","year":"2018","unstructured":"Du RH, Zhou Y, Xia ML, Lu M, Ding JH, Hu G (2018) \u03b1-Synuclein disrupts the anti-inflammatory role of Drd2 via interfering \u03b2-arrestin2-TAB1 interaction in astrocytes. J Neuroinflammation 15:258. https:\/\/doi.org\/10.1186\/s12974-018-1302-6","journal-title":"J Neuroinflammation"},{"key":"4088_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.689723","volume":"15","author":"L Dumitrescu","year":"2021","unstructured":"Dumitrescu L, Marta D, D\u0103n\u0103u A, Lefter A, Tulb\u0103 D, Cozma L, Manole E, Gherghiceanu M, Ceafalan LC, Popescu BO (2021) Serum and fecal markers of intestinal inflammation and intestinal barrier permeability are elevated in Parkinson\u2019s disease. Front Neurosci 15:689723. https:\/\/doi.org\/10.3389\/fnins.2021.689723","journal-title":"Front Neurosci"},{"key":"4088_CR48","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/j.1471-4159.2012.07826.x","volume":"122","author":"D Dutta","year":"2012","unstructured":"Dutta D, Barber DS, Zhang P, Doperalski NJ, Liu B (2012) Involvement of dopaminergic neuronal cystatin c in neuronal injury-induced microglial activation and neurotoxicity. J Neurochem 122:752\u2013763. https:\/\/doi.org\/10.1111\/j.1471-4159.2012.07826.x","journal-title":"J Neurochem"},{"key":"4088_CR49","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neuroscience.2014.10.028","volume":"302","author":"N Dzamko","year":"2015","unstructured":"Dzamko N, Geczy CL, Halliday GM (2015) Inflammation is genetically implicated in Parkinson\u2019s disease. Neuroscience 302:89\u2013102. https:\/\/doi.org\/10.1016\/j.neuroscience.2014.10.028","journal-title":"Neuroscience"},{"key":"4088_CR50","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/mds.26529","volume":"31","author":"N Dzamko","year":"2016","unstructured":"Dzamko N, Rowe DB, Halliday GM (2016) Increased peripheral inflammation in asymptomatic leucine-rich repeat kinase 2 mutation carriers. Mov Disord 31:889\u2013897. https:\/\/doi.org\/10.1002\/mds.26529","journal-title":"Mov Disord"},{"key":"4088_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101727","volume":"81","author":"M Faizan","year":"2022","unstructured":"Faizan M, Sarkar A, Singh MP (2022) Type 2 diabetes mellitus augments Parkinson\u2019s disease risk or the other way around: facts, challenges and future possibilities. Ageing Res Rev 81:101727. https:\/\/doi.org\/10.1016\/j.arr.2022.101727","journal-title":"Ageing Res Rev"},{"key":"4088_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2024.117848","volume":"556","author":"M Faizan","year":"2024","unstructured":"Faizan M, Sachan N, Verma O, Sarkar A, Rawat N, Pratap Singh M (2024) Cerebrospinal fluid protein biomarkers in Parkinson\u2019s disease. Clin Chim Acta 556:117848. https:\/\/doi.org\/10.1016\/j.cca.2024.117848","journal-title":"Clin Chim Acta"},{"key":"4088_CR53","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/436813","volume":"2011","author":"CC Ferrari","year":"2011","unstructured":"Ferrari CC, Tarelli R (2011) Parkinson\u2019s disease and systemic inflammation. Parkinsons Dis 2011:436813. https:\/\/doi.org\/10.4061\/2011\/436813","journal-title":"Parkinsons Dis"},{"key":"4088_CR54","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3389\/fncel.2018.00247","volume":"12","author":"SA Ferreira","year":"2018","unstructured":"Ferreira SA, Romero-Ramos M (2018) Microglia response during Parkinson\u2019s disease: alpha-synuclein intervention. Front Cell Neurosci 12:247. https:\/\/doi.org\/10.3389\/fncel.2018.00247","journal-title":"Front Cell Neurosci"},{"key":"4088_CR55","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3233\/JPD-202459","volume":"11","author":"V Fleury","year":"2021","unstructured":"Fleury V, Zekeridou A, Lazarevic V, Ga\u00efa N, Giannopoulou C, Genton L, Cancela J, Girard M, Goldstein R, Bally JF, Mombelli A, Schrenzel J, Burkhard PR (2021) Oral dysbiosis and inflammation in Parkinson\u2019s disease. J Parkinsons Dis 11:619\u2013631. https:\/\/doi.org\/10.3233\/JPD-202459","journal-title":"J Parkinsons Dis"},{"key":"4088_CR56","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0165-6147(03)00176-7","volume":"24","author":"HM Gao","year":"2003","unstructured":"Gao HM, Liu B, Zhang W, Hong JS (2003) Novel anti-inflammatory therapy for Parkinson\u2019s disease. Trends Pharmacol Sci 24:395\u2013401. https:\/\/doi.org\/10.1016\/S0165-6147(03)00176-7","journal-title":"Trends Pharmacol Sci"},{"key":"4088_CR57","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.ymthe.2025.01.049","volume":"33","author":"M Garcia-Gomara","year":"2025","unstructured":"Garcia-Gomara M, Legarra-Marcos N, Serena M, Rojas-de-Miguel E, Espelosin M, Marcilla I, Perez-Mediavilla A, Luquin MR, Lanciego JL, Burrell MA, Cuadrado-Tejedor M, Garcia-Osta A (2025) FKBP51 inhibition ameliorates neurodegeneration and motor dysfunction in the neuromelanin-SNCA mouse model of Parkinson\u2019s disease. Mol Ther 33:895\u2013916. https:\/\/doi.org\/10.1016\/j.ymthe.2025.01.049","journal-title":"Mol Ther"},{"key":"4088_CR58","doi-asserted-by":"publisher","first-page":"S165","DOI":"10.3233\/JPD-213138","volume":"12","author":"J Garc\u00eda-Revilla","year":"2022","unstructured":"Garc\u00eda-Revilla J, Herrera AJ, de Pablos RM, Venero JL (2022) Inflammatory animal models of Parkinson\u2019s disease. J Parkinsons Dis 12:S165\u2013S182. https:\/\/doi.org\/10.3233\/JPD-213138","journal-title":"J Parkinsons Dis"},{"key":"4088_CR59","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1016\/j.neuron.2023.07.015","volume":"111","author":"F Garretti","year":"2023","unstructured":"Garretti F, Monahan C, Sloan N, Bergen J, Shahriar S, Kim SW, Sette A, Cutforth T, Kanter E, Agalliu D, Sulzer D (2023) Interaction of an \u03b1-synuclein epitope with HLA-DRB1\u221715:01 triggers enteric features in mice reminiscent of prodromal Parkinson\u2019s disease. Neuron 111:3397-3413.e5. https:\/\/doi.org\/10.1016\/j.neuron.2023.07.015","journal-title":"Neuron"},{"key":"4088_CR60","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","volume":"21","author":"A Gerhard","year":"2006","unstructured":"Gerhard A, Pavese N, Hotton G, Turkheimer F, Es M, Hammers A, Eggert K, Oertel W, Banati RB, Brooks DJ (2006) In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson\u2019s disease. Neurobiol Dis 21:404\u2013412. https:\/\/doi.org\/10.1016\/j.nbd.2005.08.002","journal-title":"Neurobiol Dis"},{"key":"4088_CR61","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neuint.2018.12.003","volume":"124","author":"B Getachew","year":"2019","unstructured":"Getachew B, Csoka AB, Aschner M, Tizabi Y (2019) Nicotine protects against manganese and iron-induced toxicity in SH-SY5Y cells: implication for Parkinson\u2019s disease. Neurochem Int 124:19\u201324. https:\/\/doi.org\/10.1016\/j.neuint.2018.12.003","journal-title":"Neurochem Int"},{"key":"4088_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005777","volume":"4","author":"S Gispert","year":"2009","unstructured":"Gispert S, Ricciardi F, Kurz A, Azizov M, Hoepken HH, Becker D, Voos W, Leuner K, Muller WE, Kudin AP, Kunz WS, Zimmermann A, Roeper J, Wenzel D, Jendrach M, Garc\u00eda-Arenc\u00edbia M, Fern\u00e1ndez-Ruiz J, Huber L, Rohrer H, Barrera M, Reichert AS, R\u00fcb U, Chen A, Nussbaum RL, Auburger G (2009) Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration. PLoS ONE 4:e5777. https:\/\/doi.org\/10.1371\/journal.pone.0005777","journal-title":"PLoS ONE"},{"key":"4088_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105940","volume":"176","author":"A Gopinath","year":"2023","unstructured":"Gopinath A, Mackie PM, Phan LT, Tansey MG, Khoshbouei H (2023) The complex role of inflammation and gliotransmitters in Parkinson\u2019s disease. Neurobiol Dis 176:105940. https:\/\/doi.org\/10.1016\/j.nbd.2022.105940","journal-title":"Neurobiol Dis"},{"key":"4088_CR64","doi-asserted-by":"publisher","first-page":"4759","DOI":"10.1038\/s41467-024-48961-3","volume":"15","author":"J H\u00e4llqvist","year":"2024","unstructured":"H\u00e4llqvist J, Bartl M, Dakna M, Schade S, Garagnani P, Bacalini MG, Pirazzini C, Bhatia K, Schreglmann S, Xylaki M, Weber S, Ernst M, Muntean ML, Sixel-D\u00f6ring F, Franceschi C, Doykov I, \u015apiewak J, Vinette H, Trenkwalder C, Heywood WE, Mills K, Mollenhauer B (2024) Plasma proteomics identify biomarkers predicting Parkinson\u2019s disease up to 7 years before symptom onset. Nat Commun 15:4759. https:\/\/doi.org\/10.1038\/s41467-024-48961-3","journal-title":"Nat Commun"},{"key":"4088_CR65","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1039\/d3fo04714h","volume":"15","author":"D He","year":"2024","unstructured":"He D, Gao X, Wen J, Zhang Y, Yang S, Sun X, Cui M, Li Z, Fu S, Liu J, Liu D (2024a) Orally administered neohesperidin attenuates MPTP-induced neurodegeneration by inhibiting inflammatory responses and regulating intestinal flora in mice. Food Funct 15:1460\u20131475. https:\/\/doi.org\/10.1039\/d3fo04714h","journal-title":"Food Funct"},{"key":"4088_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155494","volume":"127","author":"Z He","year":"2024","unstructured":"He Z, Hu Y, Zhang Y, Xie J, Niu Z, Yang G, Zhang J, Zhao Z, WeiS WuH, Hu W (2024b) Asiaticoside exerts neuroprotection through targeting NLRP3 inflammasome activation. Phytomedicine 127:155494. https:\/\/doi.org\/10.1016\/j.phymed.2024.155494","journal-title":"Phytomedicine"},{"key":"4088_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0162717","volume":"11","author":"C Hoenen","year":"2016","unstructured":"Hoenen C, Gustin A, Birck C, Kirchmeyer M, Beaume N, Felten P, Grandbarbe L, Heuschling P, Heurtaux T (2016) Alpha-synuclein proteins promote pro-inflammatory cascades in microglia: stronger effects of the A53T mutant. PLoS ONE 11:e0162717. https:\/\/doi.org\/10.1371\/journal.pone.0162717","journal-title":"PLoS ONE"},{"key":"4088_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tox.2017.02.009","volume":"380","author":"L Hou","year":"2017","unstructured":"Hou L, Zhang C, Wang K, Liu X, Wang H, Che Y, Sun F, Zhou X, Zhao X, Wang Q (2017) Paraquat and maneb co-exposure induces noradrenergic locus coeruleus neurodegeneration through NADPH oxidase-mediated microglial activation. Toxicology 380:1\u201310. https:\/\/doi.org\/10.1016\/j.tox.2017.02.009","journal-title":"Toxicology"},{"key":"4088_CR69","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12974-020-01823-3","volume":"17","author":"L Hou","year":"2020","unstructured":"Hou L, Qu X, Qiu X, Huang R, Zhao X, Wang Q (2020) Integrin CD11b mediates locus coeruleus noradrenergic neurodegeneration in a mouse Parkinson\u2019s disease model. J Neuroinflammation 17:148. https:\/\/doi.org\/10.1186\/s12974-020-01823-3","journal-title":"J Neuroinflammation"},{"key":"4088_CR70","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1002\/mds.27326","volume":"33","author":"MC Houser","year":"2018","unstructured":"Houser MC, Chang J, Factor SA, Molho ES, Zabetian CP, Hill-Burns EM, Payami H, Hertzberg VS, Tansey MG (2018) Stool immune profiles evince gastrointestinal inflammation in Parkinson\u2019s disease. Mov Disord 33:793\u2013804. https:\/\/doi.org\/10.1002\/mds.27326","journal-title":"Mov Disord"},{"key":"4088_CR71","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.neuroscience.2020.06.001","volume":"442","author":"YJ Ji","year":"2020","unstructured":"Ji YJ, Wang HL, Yin BL, Ren XY (2020) Down-regulation of DJ-1 augments neuroinflammation via Nrf2\/Trx1\/NLRP3 axis in MPTP-induced Parkinson\u2019s disease mouse model. Neuroscience 442:253\u2013263. https:\/\/doi.org\/10.1016\/j.neuroscience.2020.06.001","journal-title":"Neuroscience"},{"key":"4088_CR72","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cellimm.2018.02.011","volume":"327","author":"MN Karpenko","year":"2018","unstructured":"Karpenko MN, Vasilishina AA, Gromova EA, Muruzheva ZM, Miliukhina IV, Bernadotte A (2018) Interleukin-1\u03b2, interleukin-1 receptor antagonist, interleukin-6, interleukin-10, and tumor necrosis factor-\u03b1 levels in CSF and serum in relation to the clinical diversity of Parkinson\u2019s disease. Cell Immunol 327:77\u201382. https:\/\/doi.org\/10.1016\/j.cellimm.2018.02.011","journal-title":"Cell Immunol"},{"key":"4088_CR73","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/emm.2006.40","volume":"38","author":"YS Kim","year":"2006","unstructured":"Kim YS, Joh TH (2006) Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson\u2019s disease. Exp Mol Med 38:333\u2013347. https:\/\/doi.org\/10.1038\/emm.2006.40","journal-title":"Exp Mol Med"},{"key":"4088_CR74","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S, Lee JH, Kim WR, Kook M, Foss CA, Shen C, Lee H, Kulkarni S, Pasricha PJ, Lee G, Pomper MG, Dawson VL, Dawson TM, Ko HS (2019) Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models Parkinson\u2019s disease. Neuron 103:627-641.e7. https:\/\/doi.org\/10.1016\/j.neuron.2019.05.035","journal-title":"Neuron"},{"key":"4088_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12017-023-08769-8","volume":"26","author":"J Kim","year":"2024","unstructured":"Kim J, Lee S, Hong DG, Yang S, Tran CS, Kwak J, Kim MJ, Rajarathinam T, Chung KW, Jung YS, Ishigami A, Chang SC, Lee H, Yun H, Lee J (2024) Amelioration of astrocyte-mediated neuroinflammation by EI-16004 confers neuroprotection in an MPTP-induced Parkinson\u2019s disease model. Neuromolecular Med 26:1. https:\/\/doi.org\/10.1007\/s12017-023-08769-8","journal-title":"Neuromolecular Med"},{"key":"4088_CR76","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1042\/BST20180462","volume":"47","author":"JH Kluss","year":"2019","unstructured":"Kluss JH, Mamais A, Cookson MR (2019) LRRK2 links genetic and sporadic Parkinson\u2019s disease. Biochem Soc Trans 47:651\u2013661. https:\/\/doi.org\/10.1042\/BST20180462","journal-title":"Biochem Soc Trans"},{"key":"4088_CR77","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.biopsych.2024.07.011","volume":"97","author":"M Krzisch","year":"2024","unstructured":"Krzisch M, Yuan B, Chen W, Osaki T, Fu D, Garrett-Engele CM, Svoboda DS, Andrykovich KR, Gallagher MD, Sur M, Jaenisch R (2024) The A53T mutation in \u03b1-synuclein enhances pro-inflammatory activation in human microglia upon inflammatory stimulus. Biol Psychiatry 97:730\u2013742. https:\/\/doi.org\/10.1016\/j.biopsych.2024.07.011","journal-title":"Biol Psychiatry"},{"key":"4088_CR78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240448","volume":"15","author":"M Kubota","year":"2020","unstructured":"Kubota M, Kobayashi N, Sugizaki T, Shimoda M, Kawahara M, Tanaka KI (2020) Carnosine suppresses neuronal cell death and inflammation induced by 6-hydroxydopamine in an in vitro model of Parkinson\u2019s disease. PLoS One 15:e0240448. https:\/\/doi.org\/10.1371\/journal.pone.0240448","journal-title":"PLoS One"},{"key":"4088_CR79","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1007\/s12035-015-9179-1","volume":"53","author":"A Kumar","year":"2016","unstructured":"Kumar A, Leinisch F, Kadiiska MB, Corbett J, Mason RP (2016a) Formation and implications of alpha-synuclein radical in maneb- and paraquat-induced models of Parkinson\u2019s disease. Mol Neurobiol 53:2983\u20132994. https:\/\/doi.org\/10.1007\/s12035-015-9179-1","journal-title":"Mol Neurobiol"},{"key":"4088_CR80","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1007\/s12035-015-9137-y","volume":"53","author":"V Kumar","year":"2016","unstructured":"Kumar V, Singh BK, Chauhan AK, Singh D, Patel DK, Singh C (2016b) Minocycline rescues from zinc-induced nigrostriatal dopaminergic neurodegeneration: biochemical and molecular interventions. Mol Neurobiol 53:2761\u20132777. https:\/\/doi.org\/10.1007\/s12035-015-9137-y","journal-title":"Mol Neurobiol"},{"key":"4088_CR81","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11010-017-3239-y","volume":"444","author":"V Kumar","year":"2018","unstructured":"Kumar V, Singh D, Singh BK, Singh S, Mittra N, Jha RR, Patel DK, Singh C (2018) Alpha-synuclein aggregation, ubiquitin proteasome system impairment, and L-dopa response in zinc-induced Parkinsonism: resemblance to sporadic Parkinson\u2019s disease. Mol Cell Biochem 444:149\u2013160. https:\/\/doi.org\/10.1007\/s11010-017-3239-y","journal-title":"Mol Cell Biochem"},{"key":"4088_CR82","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.neuro.2023.04.003","volume":"96","author":"A Kumari","year":"2023","unstructured":"Kumari A, Srivastava A, Jagdale P, Ayanur A, Khanna VK (2023) Lambda-cyhalothrin enhances inflammation in nigrostriatal region in rats: regulatory role of NF-\u03ba\u03b2 and JAK-STAT signaling. Neurotoxicology 96:101\u2013117. https:\/\/doi.org\/10.1016\/j.neuro.2023.04.003","journal-title":"Neurotoxicology"},{"key":"4088_CR83","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.2174\/0929867325666181009161048","volume":"26","author":"N Kustrimovic","year":"2019","unstructured":"Kustrimovic N, Marino F, Cosentino M (2019) Peripheral immunity, immunoaging and neuroinflammation in Parkinson\u2019s disease. Curr Med Chem 26:3719\u20133753. https:\/\/doi.org\/10.2174\/0929867325666181009161048","journal-title":"Curr Med Chem"},{"key":"4088_CR84","doi-asserted-by":"publisher","first-page":"7519","DOI":"10.3390\/ijerph120707519","volume":"12","author":"GF Kwakye","year":"2015","unstructured":"Kwakye GF, Paoliello MM, Mukhopadhyay S, Bowman AB, Aschner M (2015) Manganese-induced Parkinsonism and Parkinson\u2019s disease: shared and distinguishable features. Int J Environ Res Public Health 12:7519\u20137540. https:\/\/doi.org\/10.3390\/ijerph120707519","journal-title":"Int J Environ Res Public Health"},{"key":"4088_CR85","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.taap.2014.04.021","volume":"278","author":"JE Lee","year":"2014","unstructured":"Lee JE, Park JH, Jang SJ, Koh HC (2014) Rosiglitazone inhibits chlorpyrifos-induced apoptosis via modulation of the oxidative stress and inflammatory response in SH-SY5Y cells. Toxicol Appl Pharmacol 278:159\u2013171. https:\/\/doi.org\/10.1016\/j.taap.2014.04.021","journal-title":"Toxicol Appl Pharmacol"},{"key":"4088_CR86","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.4014\/jmb.2205.05032","volume":"32","author":"DW Lee","year":"2022","unstructured":"Lee DW, Ryu YK, Chang DH, Park HY, Go J, Maeng SY, HwangDY KBC, Lee CH, Kim KS (2022) Agathobaculum butyriciproducens shows neuroprotective effects in a 6-OHDA-induced mouse model of Parkinson\u2019s disease. J Microbiol Biotechnol 32:1168\u20131177. https:\/\/doi.org\/10.4014\/jmb.2205.05032","journal-title":"J Microbiol Biotechnol"},{"key":"4088_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2024.109586","volume":"126","author":"YH Leem","year":"2024","unstructured":"Leem YH, Park JS, Park JE, Kim DY, Kim HS (2024) Creatine supplementation with exercise reduces \u03b1-synuclein oligomerization and necroptosis in Parkinson\u2019s disease mouse model. J Nutr Biochem 126:109586. https:\/\/doi.org\/10.1016\/j.jnutbio.2024.109586","journal-title":"J Nutr Biochem"},{"key":"4088_CR88","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3892\/mmr.2021.12374","volume":"24","author":"Q Lei","year":"2021","unstructured":"Lei Q, Wu T, Wu J, Hu X, Guan Y, Wang Y, Yan J, Shi G (2021) Roles of \u03b1-synuclein in gastrointestinal microbiome dysbiosis-related Parkinson\u2019s disease progression. Mol Med Rep 24:734. https:\/\/doi.org\/10.3892\/mmr.2021.12374","journal-title":"Mol Med Rep"},{"key":"4088_CR89","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.834580","volume":"13","author":"S Lerche","year":"2022","unstructured":"Lerche S, Zimmermann M, Wurster I, Roeben B, Fries FL, Deuschle C, Waniek K, Lachmann I, Gasser T, Jakobi M, Joos TO, Schneiderhan-Marra N, Brockmann K (2022) CSF and serum levels of inflammatory markers in PD: sparse correlation, sex differences and association with neurodegenerative biomarkers. Front Neurol 13:834580. https:\/\/doi.org\/10.3389\/fneur.2022.834580","journal-title":"Front Neurol"},{"key":"4088_CR90","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41531-023-00476-2","volume":"9","author":"S Lerche","year":"2023","unstructured":"Lerche S, Zimmermann M, Roeben B, Wurster I, Fries FL, Deuschle C, Waniek K, Lachmann I, Jakobi M, Joos TO, Knorpp T, Schneiderhan-Marra N, Brockmann K (2023) Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PD. NPJ Parkinsons Dis 9:38. https:\/\/doi.org\/10.1038\/s41531-023-00476-2","journal-title":"NPJ Parkinsons Dis"},{"key":"4088_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2020.147234","volume":"1752","author":"B Li","year":"2021","unstructured":"Li B, Xia M, Zorec R, Parpura V, Verkhratsky A (2021a) Astrocytes in heavy metal neurotoxicity and neurodegeneration. Brain Res 1752:147234. https:\/\/doi.org\/10.1016\/j.brainres.2020.147234","journal-title":"Brain Res"},{"key":"4088_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.719807","volume":"12","author":"Y Li","year":"2021","unstructured":"Li Y, Xia Y, Yin S, Wan F, Hu J, Kou L, Sun Y, Wu J, Zhou Q, Huang J, Xiong N, Wang T (2021b) Targeting microglial \u03b1-Synuclein\/TLRs\/NF-kappaB\/NLRP3 inflammasome axis in Parkinson\u2019s Disease. Front Immunol 12:719807. https:\/\/doi.org\/10.3389\/fimmu.2021.719807","journal-title":"Front Immunol"},{"key":"4088_CR93","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.bbi.2019.07.026","volume":"81","author":"Z Liu","year":"2019","unstructured":"Liu Z, Qiu AW, Huang Y, Yang Y, Chen JN, Gu TT, Cao BB, Qiu YH, Peng YP (2019) IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson\u2019s disease. Brain Behav Immun 81:630\u2013645. https:\/\/doi.org\/10.1016\/j.bbi.2019.07.026","journal-title":"Brain Behav Immun"},{"key":"4088_CR94","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/WNR.0000000000001997","volume":"35","author":"L Liu","year":"2024","unstructured":"Liu L, Jiang L, Zhang J, Ma Y, Wan M, Hu X, Yang L (2024) Imperatorin inhibits oxidative stress injury and neuroinflammation via the PI3K\/AKT signaling pathway in the MPTP-induced Parkinson\u2019s disease mouse. NeuroReport 35:175\u2013184. https:\/\/doi.org\/10.1097\/WNR.0000000000001997","journal-title":"NeuroReport"},{"key":"4088_CR95","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jneuroim.2010.05.030","volume":"226","author":"CM Long-Smith","year":"2010","unstructured":"Long-Smith CM, Collins L, Toulouse A, Sullivan AM, Nolan YM (2010) Interleukin-1\u03b2 contributes to dopaminergic neuronal death induced by lipopolysaccharide-stimulated rat glia in vitro. J Neuroimmunol 226:20\u201326. https:\/\/doi.org\/10.1016\/j.jneuroim.2010.05.030","journal-title":"J Neuroimmunol"},{"key":"4088_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2022.136547","volume":"775","author":"M Luan","year":"2022","unstructured":"Luan M, Jin J, Wang Y, Li X, Xie A (2022) Association of PGLYRP2 gene polymorphism and sporadic Parkinson\u2019s disease in northern Chinese Han population. Neurosci Lett 775:136547. https:\/\/doi.org\/10.1016\/j.neulet.2022.136547","journal-title":"Neurosci Lett"},{"key":"4088_CR97","doi-asserted-by":"publisher","first-page":"6083","DOI":"10.1038\/s41380-021-01207-w","volume":"26","author":"J Magalhaes","year":"2021","unstructured":"Magalhaes J, Tresse E, Ejlerskov P, Hu E, Liu Y, Marin A, Montalant A, Satriano L, Rundsten CF, Carlsen EMM, Rydbirk R, Sharifi-Zarchi A, Andersen JB, Aznar S, Brudek T, Khodosevich K, Prinz M, Perrier JM, Sharma M, Gasser T, Issazadeh-Navikas S (2021) PIAS2-mediated blockade of IFN-\u03b2 signaling: a basis for sporadic Parkinson disease dementia. Mol Psychiatry 26:6083\u20136099. https:\/\/doi.org\/10.1038\/s41380-021-01207-w","journal-title":"Mol Psychiatry"},{"key":"4088_CR98","doi-asserted-by":"publisher","first-page":"4459","DOI":"10.1007\/s10072-021-05551-1","volume":"42","author":"S Mani","year":"2021","unstructured":"Mani S, Sevanan M, Krishnamoorthy A, Sekar S (2021) A systematic review of molecular approaches that link mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease. Neurol Sci 42:4459\u20134469. https:\/\/doi.org\/10.1007\/s10072-021-05551-1","journal-title":"Neurol Sci"},{"key":"4088_CR99","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","volume":"287","author":"E Masliah","year":"2000","unstructured":"Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, Sagara Y, Sisk A, Mucke L (2000) Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287:1265\u20131269. https:\/\/doi.org\/10.1126\/science.287.5456.1265","journal-title":"Science"},{"key":"4088_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106701","volume":"202","author":"CM Massari","year":"2024","unstructured":"Massari CM, Dues DJ, Bergsma A, Sipple K, Frye M, Williams ET, Moore DJ (2024) Neuropathology in an \u03b1-synuclein preformed fibril mouse model occurs independent of the Parkinson\u2019s disease-linked lysosomal ATP13A2 protein. Neurobiol Dis 202:106701. https:\/\/doi.org\/10.1016\/j.nbd.2024.106701","journal-title":"Neurobiol Dis"},{"key":"4088_CR101","doi-asserted-by":"publisher","first-page":"9365","DOI":"10.1523\/JNEUROSCI.1504-06.2006","volume":"26","author":"MK McCoy","year":"2006","unstructured":"McCoy MK, Martinez TN, Ruhn KA, Szymkowski DE, Smith CG, Botterman BR, Tansey KE, Tansey MG (2006) Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson\u2019s disease. J Neurosci 26:9365\u20139375. https:\/\/doi.org\/10.1523\/JNEUROSCI.1504-06.2006","journal-title":"J Neurosci"},{"key":"4088_CR102","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s12640-017-9825-7","volume":"33","author":"FA McLeary","year":"2018","unstructured":"McLeary FA, Rcom-H\u2019cheo-Gauthier AN, Kinder J, Goulding M, Khoo TK, Mellick GD, Chung RS, Pountney DL (2018) Dexamethasone inhibits copper-induced alpha-synuclein aggregation by a metallothionein-dependent mechanism. Neurotox Res 33:229\u2013238. https:\/\/doi.org\/10.1007\/s12640-017-9825-7","journal-title":"Neurotox Res"},{"key":"4088_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155309","volume":"124","author":"T Meng","year":"2024","unstructured":"Meng T, Zhang Y, Huang J, Pandey V, Fu S, Ma S (2024) Rubusoside mitigates neuroinflammation and cellular apoptosis in Parkinson\u2019s disease, and alters gut microbiota and metabolite composition. Phytomedicine 124:155309. https:\/\/doi.org\/10.1016\/j.phymed.2023.155309","journal-title":"Phytomedicine"},{"key":"4088_CR104","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10517-020-04723-x","volume":"168","author":"IV Miliukhina","year":"2020","unstructured":"Miliukhina IV, Usenko TS, Senkevich KA, Nikolaev MA, Timofeeva AA, Agapova EA, Semenov AV, Lubimova NE, Totolyan AA, Pchelina SN (2020) Plasma cytokines profile in patients with Parkinson\u2019s disease associated with mutations in GBA gene. Bull Exp Biol Med 168:423\u2013426. https:\/\/doi.org\/10.1007\/s10517-020-04723-x","journal-title":"Bull Exp Biol Med"},{"key":"4088_CR105","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s00018-011-0850-z","volume":"69","author":"G Mud\u00f2","year":"2012","unstructured":"Mud\u00f2 G, M\u00e4kel\u00e4 J, Di Liberto V, Tselykh TV, Olivieri M, Piepponen P, Eriksson O, M\u00e4lki\u00e4 A, Bonomo A, Kairisalo M, Aguirre JA, Korhonen L, Belluardo N, Lindholm D (2012) Transgenic expression and activation of PGC-1\u03b1 protect dopaminergic neurons in the MPTP mouse model of Parkinson\u2019s disease. Cell Mol Life Sci 69:1153\u20131165. https:\/\/doi.org\/10.1007\/s00018-011-0850-z","journal-title":"Cell Mol Life Sci"},{"key":"4088_CR106","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/mds.29369","volume":"38","author":"L Mu\u00f1oz-Delgado","year":"2023","unstructured":"Mu\u00f1oz-Delgado L, Labrador-Espinosa M\u00c1, Mac\u00edas-Garc\u00eda D, Jes\u00fas S, Ben\u00edtez Zamora B, Fern\u00e1ndez-Rodr\u00edguez P, Adarmes-G\u00f3mez AD, Reina Castillo MI, Castro-Labrador S, Silva-Rodr\u00edguez J, Carrillo F, Garc\u00eda Sol\u00eds D, Grothe MJ, Mir P (2023) Peripheral inflammation is associated with dopaminergic degeneration in Parkinson\u2019s disease. Mov Disord 38:755\u2013763. https:\/\/doi.org\/10.1002\/mds.29369","journal-title":"Mov Disord"},{"key":"4088_CR107","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.742065","volume":"15","author":"L Muzio","year":"2021","unstructured":"Muzio L, Viotti A, Martino G (2021) Microglia in neuroinflammation and neurodegeneration: from understanding to therapy. Front Neurosci 15:742065. https:\/\/doi.org\/10.3389\/fnins.2021.742065","journal-title":"Front Neurosci"},{"key":"4088_CR108","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1089\/ars.2013.5703","volume":"20","author":"Z Nayernia","year":"2014","unstructured":"Nayernia Z, Jaquet V, Krause KH (2014) New insights on NOX enzymes in the central nervous system. Antioxid Redox Signal 20:2815\u20132837. https:\/\/doi.org\/10.1089\/ars.2013.5703","journal-title":"Antioxid Redox Signal"},{"key":"4088_CR109","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41522-022-00367-z","volume":"8","author":"S Nie","year":"2022","unstructured":"Nie S, Wang J, Deng Y, YeZ GY (2022) Inflammatory microbes and genes as potential biomarkers of Parkinson\u2019s disease. NPJ Biofilms Microbiomes 8:101. https:\/\/doi.org\/10.1038\/s41522-022-00367-z","journal-title":"NPJ Biofilms Microbiomes"},{"key":"4088_CR110","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.3390\/cells9071687","volume":"9","author":"M Pajares","year":"2020","unstructured":"Pajares M, Rojo AI, Manda G, Bosc\u00e1 L, Cuadrado A (2020) Inflammation in Parkinson\u2019s disease: mechanisms and therapeutic implications. Cells 9:1687. https:\/\/doi.org\/10.3390\/cells9071687","journal-title":"Cells"},{"key":"4088_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.104879","volume":"299","author":"E Pajarillo","year":"2023","unstructured":"Pajarillo E, Kim S, Digman A, Dutton M, Son DS, Aschner M, Lee E (2023) The role of microglial LRRK2 kinase in manganese-induced inflammatory neurotoxicity via NLRP3 inflammasome and RAB10-mediated autophagy dysfunction. J Biol Chem 299:104879. https:\/\/doi.org\/10.1016\/j.jbc.2023.104879","journal-title":"J Biol Chem"},{"key":"4088_CR112","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40035-019-0165-9","volume":"8","author":"SY Pang","year":"2019","unstructured":"Pang SY, Ho PW, Liu HF, Leung CT, Li L, Chang EES, Ramsden DB, Ho SL (2019) The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson\u2019s disease. Transl Neurodegener 8:23. https:\/\/doi.org\/10.1186\/s40035-019-0165-9","journal-title":"Transl Neurodegener"},{"key":"4088_CR113","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.neuron.2022.05.009","volume":"110","author":"N Panicker","year":"2022","unstructured":"Panicker N, Kam TI, Wang H, Neifert S, Chou SC, Kumar M, Brahmachari S, Jhaldiyal A, Hinkle JT, Akkentli F, Mao X, Xu E, Karuppagounder SS, Hsu ET, Kang SU, Pletnikova O, Troncoso J, Dawson VL, Dawson TM (2022) Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson\u2019s disease. Neuron 110:2422-2437.e9. https:\/\/doi.org\/10.1016\/j.neuron.2022.05.009","journal-title":"Neuron"},{"key":"4088_CR114","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/s41586-023-06300-4","volume":"619","author":"TY Park","year":"2023","unstructured":"Park TY, Jeon J, Lee N, Kim J, Song B, Kim JH, Lee SK, Liu D, Cha Y, Kim M, Leblanc P, Herrington TM, Carter BS, Schweitzer JS, Kim KS (2023) Co-transplantation of autologous Treg cells in a cell therapy for Parkinson\u2019s disease. Nature 619:606\u2013615. https:\/\/doi.org\/10.1038\/s41586-023-06300-4","journal-title":"Nature"},{"key":"4088_CR115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12640-019-00104-z","volume":"37","author":"I Parra","year":"2020","unstructured":"Parra I, Mart\u00ednez I, Ram\u00edrez-Garc\u00eda G, Tizabi Y, Mendieta L (2020) Differential effects of LPS and 6-OHDA on microglia\u2019s morphology in rats: implications for inflammatory model of Parkinson\u2019s disease. Neurotox Res 37:1\u201311. https:\/\/doi.org\/10.1007\/s12640-019-00104-z","journal-title":"Neurotox Res"},{"key":"4088_CR116","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.853372","volume":"14","author":"G Paul","year":"2022","unstructured":"Paul G, Elabi OF (2022) Microvascular changes in Parkinson\u2019s disease- focus on the neurovascular unit. Front Aging Neurosci 14:853372. https:\/\/doi.org\/10.3389\/fnagi.2022.853372","journal-title":"Front Aging Neurosci"},{"key":"4088_CR117","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/401264","volume":"2012","author":"LJ Peterson","year":"2012","unstructured":"Peterson LJ, Flood PM (2012) Oxidative stress and microglial cells in Parkinson\u2019s disease. Mediators Inflamm 2012:401264. https:\/\/doi.org\/10.1155\/2012\/401264","journal-title":"Mediators Inflamm"},{"key":"4088_CR118","doi-asserted-by":"publisher","first-page":"6774","DOI":"10.1007\/s12035-023-03485-7","volume":"60","author":"RJ Ram\u00edrez-Carreto","year":"2023","unstructured":"Ram\u00edrez-Carreto RJ, Zald\u00edvar-Machorro VJ, P\u00e9rez-Ram\u00edrez DJ, Rodr\u00edguez-L\u00f3pez BE, Meza C, Garc\u00eda E, Santamar\u00eda A, Chavarr\u00eda A (2023) Oral administration of silybin protects against MPTP-induced neurotoxicity by reducing pro-inflammatory cytokines and preserving BDNF levels in mice. Mol Neurobiol 60:6774\u20136788. https:\/\/doi.org\/10.1007\/s12035-023-03485-7","journal-title":"Mol Neurobiol"},{"key":"4088_CR119","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1177\/07482337241267192","volume":"40","author":"N Rawat","year":"2024","unstructured":"Rawat N, Singh MP (2024) Effect of chlorpyrifos on cypermethrin-induced dopaminergic neurotoxicity in rats. Toxicol Ind Health 40:530\u2013538. https:\/\/doi.org\/10.1177\/07482337241267192","journal-title":"Toxicol Ind Health"},{"key":"4088_CR120","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bbi.2008.07.003","volume":"23","author":"M Reale","year":"2009","unstructured":"Reale M, Iarlori C, Thomas A, Gambi D, Perfetti B, Di Nicola M, Onofrj M (2009) Peripheral cytokines profile in Parkinson\u2019s disease. Brain Behav Immun 23:55\u201363. https:\/\/doi.org\/10.1016\/j.bbi.2008.07.003","journal-title":"Brain Behav Immun"},{"key":"4088_CR121","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1600-0404.2007.00894.x","volume":"116","author":"M Rentzos","year":"2007","unstructured":"Rentzos M, Nikolaou C, Andreadou E, Paraskevas GP, Rombos A, Zoga M, Tsoutsou A, Boufidou F, Kapaki E, Vassilopoulos D (2007) Circulating interleukin-15 and rantes chemokine in Parkinson\u2019s disease. Acta Neurol Scand 116:374\u2013379. https:\/\/doi.org\/10.1111\/j.1600-0404.2007.00894.x","journal-title":"Acta Neurol Scand"},{"key":"4088_CR122","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00702-023-02630-9","volume":"130","author":"P Riederer","year":"2023","unstructured":"Riederer P, Nagatsu T, Youdim MBH, Wulf M, Dijkstra JM, Sian-Huelsmann J (2023) Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson\u2019s disease. J Neural Transm (Vienna) 130:627\u2013646. https:\/\/doi.org\/10.1007\/s00702-023-02630-9","journal-title":"J Neural Transm (Vienna)"},{"key":"4088_CR123","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neuro.2021.07.004","volume":"86","author":"A Rizor","year":"2021","unstructured":"Rizor A, Pajarillo E, Nyarko-Danquah I, Digman A, Mooneyham L, Son DS, Aschner M, Lee E (2021) Manganese-induced reactive oxygen species activate I\u03baB kinase to upregulate YY1 and impair glutamate transporter EAAT2 function in human astrocytes in vitro. Neurotoxicology 86:94\u2013103. https:\/\/doi.org\/10.1016\/j.neuro.2021.07.004","journal-title":"Neurotoxicology"},{"key":"4088_CR124","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12974-015-0449-7","volume":"12","author":"I Russo","year":"2015","unstructured":"Russo I, Berti G, Plotegher N, Bernardo G, Filograna R, Bubacco L, Greggio E (2015) Leucine-rich repeat kinase 2 positively regulates inflammation and down-regulates NF-\u03baB p50 signaling in cultured microglia cells. J Neuroinflammation 12:230. https:\/\/doi.org\/10.1186\/s12974-015-0449-7","journal-title":"J Neuroinflammation"},{"key":"4088_CR125","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41593-022-01221-3","volume":"26","author":"SK Ryan","year":"2023","unstructured":"Ryan SK, Zelic M, Han Y, Teeple E, Chen L, Sadeghi M, Shankara S, Guo L, Li C, Pontarelli F, Jensen EH, Comer AL, Kumar D, Zhang M, Gans J, Zhang B, Proto JD, Saleh J, Dodge JC, Savova V, Rajpal D, Ofengeim D, Hammond TR (2023) Microglia ferroptosis is regulated by SEC24B and contributes to neurodegeneration. Nat Neurosci 26:12\u201326. https:\/\/doi.org\/10.1038\/s41593-022-01221-3","journal-title":"Nat Neurosci"},{"key":"4088_CR126","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12883-020-1608-8","volume":"20","author":"A Santaella","year":"2020","unstructured":"Santaella A, Kuiperij HB, van Rumund A, Esselink RAJ, van Gool AJ, Bloem BR, Verbeek MM (2020) Inflammation biomarker discovery in Parkinson\u2019s disease and atypical parkinsonisms. BMC Neurol 20:26. https:\/\/doi.org\/10.1186\/s12883-020-1608-8","journal-title":"BMC Neurol"},{"key":"4088_CR127","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.bbi.2009.10.015","volume":"24","author":"C Sarkar","year":"2010","unstructured":"Sarkar C, Basu B, Chakroborty D, Dasgupta PS, Basu S (2010) The immunoregulatory role of dopamine: an update. Brain Behav Immun 24:525\u2013528. https:\/\/doi.org\/10.1016\/j.bbi.2009.10.015","journal-title":"Brain Behav Immun"},{"key":"4088_CR128","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jneuroim.2009.08.001","volume":"216","author":"P Scalzo","year":"2009","unstructured":"Scalzo P, K\u00fcmmer A, Cardoso F, Teixeira AL (2009) Increased serum levels of soluble tumor necrosis factor-alpha receptor-1 in patients with Parkinson\u2019s disease. J Neuroimmunol 216:122\u2013125. https:\/\/doi.org\/10.1016\/j.jneuroim.2009.08.001","journal-title":"J Neuroimmunol"},{"key":"4088_CR129","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41531-024-00704-3","volume":"10","author":"SL Schaffner","year":"2024","unstructured":"Schaffner SL, Casazza W, Artaud F, Konwar C, Merrill SM, Domenighetti C, Schulze-Hentrich JM, Lesage S, Brice A, Corvol JC, Mostafavi S, Dennis JK, Elbaz A, Kobor MS, DIGPD Study Group (2024) Genetic variation and pesticide exposure influence blood DNA methylation signatures in females with early stage Parkinson\u2019s disease. NPJ Parkinsons 10:98. https:\/\/doi.org\/10.1038\/s41531-024-00704-3","journal-title":"NPJ Parkinsons"},{"key":"4088_CR130","doi-asserted-by":"publisher","first-page":"E157","DOI":"10.1152\/ajpendo.00578.2013","volume":"306","author":"S Sczelecki","year":"2014","unstructured":"Sczelecki S, Besse-Patin A, Abboud A, Kleiner S, Laznik-Bogoslavski D, Wrann CD, Ruas JL, Haibe-Kains B, Estall JL (2014) Loss of Pgc-1\u03b1 expression in aging mouse muscle potentiates glucose intolerance and systemic inflammation. Am J Physiol Endocrinol Metab 306:E157-167. https:\/\/doi.org\/10.1152\/ajpendo.00578.2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4088_CR131","doi-asserted-by":"publisher","first-page":"11416","DOI":"10.3390\/ijms241411416","volume":"24","author":"ML Sheu","year":"2023","unstructured":"Sheu ML, Pan LY, Yang CN, Sheehan J, Pan LY, You WC, Wang CC, Pan HC (2023) Thrombin-induced microglia activation modulated through aryl hydrocarbon receptors. Int J Mol Sci 24:11416. https:\/\/doi.org\/10.3390\/ijms241411416","journal-title":"Int J Mol Sci"},{"key":"4088_CR132","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s12640-009-9076-3","volume":"16","author":"M Shimoji","year":"2009","unstructured":"Shimoji M, Pagan F, Healton EB, Mocchetti I (2009) CXCR4 and CXCL12 expression is increased in the nigrostriatal system of Parkinson\u2019s disease. Neurotox Res 16:318\u2013328. https:\/\/doi.org\/10.1007\/s12640-009-9076-3","journal-title":"Neurotox Res"},{"key":"4088_CR133","doi-asserted-by":"publisher","first-page":"6849","DOI":"10.1007\/s12035-015-9577-4","volume":"53","author":"A Singh","year":"2016","unstructured":"Singh A, Tripathi P, Prakash O, Singh MP (2016) Ibuprofen abates cypermethrin-induced expression of pro-inflammatory mediators and mitogen-activated protein kinases and averts the nigrostriatal dopaminergic neurodegeneration. Mol Neurobiol 53:6849\u20136858. https:\/\/doi.org\/10.1007\/s12035-015-9577-4","journal-title":"Mol Neurobiol"},{"key":"4088_CR134","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1002\/glia.23482","volume":"66","author":"K Singh","year":"2018","unstructured":"Singh K, Han K, Tilve S, Wu K, Geller HM, Sack MN (2018) Parkin targets NOD2 to regulate astrocyte endoplasmic reticulum stress and inflammation. Glia 66:2427\u20132437. https:\/\/doi.org\/10.1002\/glia.23482","journal-title":"Glia"},{"key":"4088_CR135","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11010-013-1780-x","volume":"384","author":"NK Singhal","year":"2013","unstructured":"Singhal NK, Chauhan AK, Jain SK, Shanker R, Singh C, Singh MP (2013) Silymarin- and melatonin-mediated changes in the expression of selected genes in pesticides-induced Parkinsonism. Mol Cell Biochem 384:47\u201358. https:\/\/doi.org\/10.1007\/s11010-013-1780-x","journal-title":"Mol Cell Biochem"},{"key":"4088_CR136","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s12035-014-8643-7","volume":"50","author":"N Singla","year":"2014","unstructured":"Singla N, Dhawan DK (2014) Influence of zinc on calcium-dependent signal transduction pathways during aluminium-induced neurodegeneration. Mol Neurobiol 50:613\u2013625. https:\/\/doi.org\/10.1007\/s12035-014-8643-7","journal-title":"Mol Neurobiol"},{"key":"4088_CR137","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","volume":"127","author":"J St-Pierre","year":"2006","unstructured":"St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, J\u00e4ger S, Handschin C, Zheng K, Lin J, Yang W, Simon DK, Bachoo R, Spiegelman BM (2006) Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127:397\u2013408. https:\/\/doi.org\/10.1016\/j.cell.2006.09.024","journal-title":"Cell"},{"key":"4088_CR138","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.651971","volume":"12","author":"C Strafella","year":"2021","unstructured":"Strafella C, Caputo V, Termine A, Assogna F, Pellicano C, Pontieri FE, Macchiusi L, Minozzi G, Gambardella S, Centonze D, Boss\u00f9 P, Spalletta G, Caltagirone C, Giardina E, Cascella R (2021) Immune system and neuroinflammation in idiopathic Parkinson\u2019s disease: association analysis of genetic variants and miRNAs interactions. Front Genet 12:651971. https:\/\/doi.org\/10.3389\/fgene.2021.651971","journal-title":"Front Genet"},{"key":"4088_CR139","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.644219","volume":"12","author":"CF Su","year":"2021","unstructured":"Su CF, Jiang L, Zhang XW, Iyaswamy A, Li M (2021) Resveratrol in rodent models of Parkinson\u2019s disease: a systematic review of experimental studies. Front Pharmacol 12:644219. https:\/\/doi.org\/10.3389\/fphar.2021.644219","journal-title":"Front Pharmacol"},{"key":"4088_CR140","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1021\/acschemneuro.7b00478","volume":"9","author":"Y Sun","year":"2018","unstructured":"Sun Y, Pham AN, Waite TD (2018) Mechanism underlying the effectiveness of deferiprone in alleviating Parkinson\u2019s disease symptoms. ACS Chem Neurosci 9:1118\u20131127. https:\/\/doi.org\/10.1021\/acschemneuro.7b00478","journal-title":"ACS Chem Neurosci"},{"key":"4088_CR141","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1134\/S1819712423020149","volume":"17","author":"W Sun","year":"2023","unstructured":"Sun W, Zuo PH, Li HH, Xiao H, Wang Q (2023) Blockage of CXCR2 activity suppressed inflammatory cytokine release and ferroptosis in rotenone-Induced SH-SY5Y cell model with PD-like lesions. Neurochem J 17:270\u2013281. https:\/\/doi.org\/10.1134\/S1819712423020149","journal-title":"Neurochem J"},{"key":"4088_CR142","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/fcp.12817","volume":"36","author":"PC Tiwari","year":"2022","unstructured":"Tiwari PC, Chaudhary MJ, Pal R, Nath R (2022) Effects of mangiferin and its combination with nNOS inhibitor 7-nitro-indazole (7-NI) in 6-hydroxydopamine (6-OHDA) lesioned Parkinson\u2019s disease rats. Fundam Clin Pharmacol 36:944\u2013955. https:\/\/doi.org\/10.1111\/fcp.12817","journal-title":"Fundam Clin Pharmacol"},{"key":"4088_CR143","doi-asserted-by":"publisher","unstructured":"Troncoso-Escudero P, Parra A, Nassif M, Vidal RL (2018) Outside in: unraveling the role of neuroinflammation in the progression of Parkinson\u2019s disease. Front Neurol 9:860. https:\/\/doi.org\/10.3389\/fneur.2018.00860","DOI":"10.3389\/fneur.2018.00860"},{"key":"4088_CR144","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.bbrc.2019.02.076","volume":"511","author":"R Tsutsumi","year":"2019","unstructured":"Tsutsumi R, Hori Y, Seki T, Kurauchi Y, Sato M, Oshima M, Hisatsune A, Katsuki H (2019) Involvement of exosomes in dopaminergic neurodegeneration by microglial activation in midbrain slice cultures. Biochem Biophys Res Commun 511:427\u2013433. https:\/\/doi.org\/10.1016\/j.bbrc.2019.02.076","journal-title":"Biochem Biophys Res Commun"},{"key":"4088_CR145","doi-asserted-by":"publisher","first-page":"4628","DOI":"10.3390\/ijms24054628","volume":"24","author":"IE Valenzuela-Arzeta","year":"2023","unstructured":"Valenzuela-Arzeta IE, Soto-Rojas LO, Flores-Martinez YM, Delgado-Minjares KM, Gatica-Garcia B, Mascotte-Cruz JU, Nava P, Aparicio-Trejo OE, Reyes-Corona D, Mart\u00ednez-D\u00e1vila IA, Gutierrez-Castillo ME, Espadas-Alvarez AJ, Orozco-Barrios CE, Martinez-Fong D (2023) LPS triggers acute neuroinflammation and parkinsonism involving NLRP3 inflammasome pathway and mitochondrial CI dysfunction in the rat. Int J Mol Sci 24:4628. https:\/\/doi.org\/10.3390\/ijms24054628","journal-title":"Int J Mol Sci"},{"key":"4088_CR146","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1111\/j.1471-4159.2010.06879.x","volume":"114","author":"RF Villar\u00e1n","year":"2010","unstructured":"Villar\u00e1n RF, Espinosa-Oliva AM, Sarmiento M, De Pablos RM, Arg\u00fcelles S, Delgado-Cort\u00e9s MJ, Sobrino V, Van Rooijen N, Venero JL, Herrera AJ, Cano J, Machado A (2010) Ulcerative colitis exacerbates lipopolysaccharide-induced damage to the nigral dopaminergic system: potential risk factor in Parkinson`s disease. J Neurochem 114:1687\u20131700. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.06879.x","journal-title":"J Neurochem"},{"key":"4088_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109691","volume":"122","author":"JL Wang","year":"2020","unstructured":"Wang JL, Xu CJ (2020) Astrocytes autophagy in aging and neurodegenerative disorders. Biomed Pharmacother 122:109691. https:\/\/doi.org\/10.1016\/j.biopha.2019.109691","journal-title":"Biomed Pharmacother"},{"key":"4088_CR148","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","volume":"4","author":"Q Wang","year":"2015","unstructured":"Wang Q, Liu Y, Zhou J (2015) Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target. Transl Neurodegener 4:19. https:\/\/doi.org\/10.1186\/s40035-015-0042-0","journal-title":"Transl Neurodegener"},{"key":"4088_CR149","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.2147\/JIR.S301531","volume":"14","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhang X, Chen F, Chen L, Wang J, Xie J (2021) LRRK2-NFATc2 Pathway associated with neuroinflammation may be a potential therapeutic target for Parkinson\u2019s disease. J Inflamm Res 14:2583\u20132586. https:\/\/doi.org\/10.2147\/JIR.S301531","journal-title":"J Inflamm Res"},{"key":"4088_CR150","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1021\/acs.jafc.1c07711","volume":"70","author":"L Wang","year":"2022","unstructured":"Wang L, Zhao Z, Zhao L, Zhao Y, Yang G, Wang C, Gao L, Niu C, Li S (2022) Lactobacillus plantarum DP189 reduces \u03b1-SYN aggravation in MPTP-induced Parkinson\u2019s disease mice via regulating oxidative damage, inflammation, and gut microbiota disorder. J Agric Food Chem 70:1163\u20131173. https:\/\/doi.org\/10.1021\/acs.jafc.1c07711","journal-title":"J Agric Food Chem"},{"key":"4088_CR151","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41531-022-00430-8","volume":"9","author":"H Wang","year":"2023","unstructured":"Wang H, Chen G, Ahn EH, Xia Y, Kang SS, Liu X, Liu C, Han MH, Chen S, Ye K (2023) C\/EBP\u03b2\/AEP is age-dependently activated in Parkinson\u2019s disease and mediates \u03b1-synuclein in the gut and brain. NPJ Parkinsons Dis 9:1. https:\/\/doi.org\/10.1038\/s41531-022-00430-8","journal-title":"NPJ Parkinsons Dis"},{"key":"4088_CR152","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12967-024-04881-w","volume":"22","author":"D Wang","year":"2024","unstructured":"Wang D, Gao H, Qin Q, Li J, Zhao J, Qu Y, Li J, Xiong Y, Min Z, Mao Z, Xue Z (2024) MicroRNA-218-5p-Ddx41 axis restrains microglia-mediated neuroinflammation through downregulating type I interferon response in a mouse model of Parkinson\u2019s disease. J Transl Med 22:63. https:\/\/doi.org\/10.1186\/s12967-024-04881-w","journal-title":"J Transl Med"},{"key":"4088_CR153","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1042\/BST20150014","volume":"43","author":"JD Wardyn","year":"2015","unstructured":"Wardyn JD, Ponsford AH, Sanderson CM (2015) Dissecting molecular cross-talk between Nrf2 and NF-\u03baB response pathways. Biochem Soc Trans 43:621\u2013626. https:\/\/doi.org\/10.1042\/BST20150014","journal-title":"Biochem Soc Trans"},{"key":"4088_CR154","doi-asserted-by":"publisher","first-page":"2529641","DOI":"10.1155\/2019\/2529641","volume":"2019","author":"R Wei","year":"2019","unstructured":"Wei R, Rong C, Xie Q, Wu S, Feng Y, Wang R, Dai Z, Lin T (2019) Neuroprotective effect of optimized yinxieling formula in 6-OHDA-induced chronic model of Parkinson\u2019s disease through the inflammation pathway. Evid Based Complement Alternat Med 2019:2529641. https:\/\/doi.org\/10.1155\/2019\/2529641","journal-title":"Evid Based Complement Alternat Med"},{"issue":"s1","key":"4088_CR155","doi-asserted-by":"publisher","first-page":"S129","DOI":"10.3233\/JPD-223241","volume":"12","author":"GP Williams","year":"2022","unstructured":"Williams GP, Schonhoff AM, Sette A, Lindestam Arlehamn CS (2022) Central and peripheral inflammation: connecting the immune responses of Parkinson\u2019s disease. J Parkinsons Dis 12(s1):S129\u2013S136. https:\/\/doi.org\/10.3233\/JPD-223241","journal-title":"J Parkinsons Dis"},{"key":"4088_CR156","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41582-022-00631-y","volume":"18","author":"H Wood","year":"2022","unstructured":"Wood H (2022) \u03b1-Synuclein-activated microglia are implicated in PD pathogenesis. Nat Rev Neurol 18:188. https:\/\/doi.org\/10.1038\/s41582-022-00631-y","journal-title":"Nat Rev Neurol"},{"key":"4088_CR157","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2023.114614","volume":"372","author":"Z Xiao","year":"2024","unstructured":"Xiao Z, Wang X, Pan X, Xie J, Xu H (2024) Mitochondrial iron dyshomeostasis and its potential as a therapeutic target for Parkinson\u2019s disease. Exp Neurol 372:114614. https:\/\/doi.org\/10.1016\/j.expneurol.2023.114614","journal-title":"Exp Neurol"},{"key":"4088_CR158","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3389\/fnmol.2017.00455","volume":"10","author":"H Xu","year":"2018","unstructured":"Xu H, Wang Y, Song N, Wang J, Jiang H, Xie J (2018) New progress on the role of glia in iron metabolism and iron-induced degeneration of dopamine neurons in Parkinson\u2019s disease. Front Mol Neurosci 10:455. https:\/\/doi.org\/10.3389\/fnmol.2017.00455","journal-title":"Front Mol Neurosci"},{"key":"4088_CR159","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/acn3.51512","volume":"9","author":"J Xu","year":"2022","unstructured":"Xu J, He X, Xu Y, Chen X, Li M, Zhang L, Fu X, Pan M, Wang Q, Hu X (2022) Characteristics of systemic inflammation and brain iron deposition in Parkinson\u2019s disease patients. Ann Clin Transl Neurol 9:276\u2013285. https:\/\/doi.org\/10.1002\/acn3.51512","journal-title":"Ann Clin Transl Neurol"},{"key":"4088_CR160","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s11064-011-0682-0","volume":"37","author":"S Yadav","year":"2012","unstructured":"Yadav S, Gupta SP, Srivastava G, Srivastava PK, Singh MP (2012) Role of secondary mediators in caffeine-mediated neuroprotection in maneb- and paraquat-induced Parkinson\u2019s disease phenotype in the mouse. Neurochem Res 37:875\u2013884. https:\/\/doi.org\/10.1007\/s11064-011-0682-0","journal-title":"Neurochem Res"},{"key":"4088_CR161","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.neuroscience.2020.08.004","volume":"446","author":"YQ Yan","year":"2020","unstructured":"Yan YQ, Fang Y, Zheng R, Pu JL, Zhang BR (2020) NLRP3 inflammasomes in Parkinson\u2019s disease and their regulation by parkin. Neuroscience 446:323\u2013334. https:\/\/doi.org\/10.1016\/j.neuroscience.2020.08.004","journal-title":"Neuroscience"},{"key":"4088_CR162","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2023.114872","volume":"256","author":"D Yan","year":"2023","unstructured":"Yan D, Yang Y, Lang J, Wang X, Huang Y, Meng J, Wu J, Zeng X, Li H, Ma H, Gao L (2023) SIRT1\/FOXO3-mediated autophagy signaling involved in manganese-induced neuroinflammation in microglia. Ecotoxicol Environ Saf 256:114872. https:\/\/doi.org\/10.1016\/j.ecoenv.2023.114872","journal-title":"Ecotoxicol Environ Saf"},{"key":"4088_CR163","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/iji.12549","volume":"48","author":"H Yang","year":"2021","unstructured":"Yang H (2021) LncRNA MALAT1 potentiates inflammation disorder in Parkinson\u2019s disease. Int J Immunogenet 48:419\u2013428. https:\/\/doi.org\/10.1111\/iji.12549","journal-title":"Int J Immunogenet"},{"key":"4088_CR164","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2022.166365","volume":"1868","author":"Y Yang","year":"2022","unstructured":"Yang Y, Zhang S, Guan J, Jiang Y, Zhang J, Luo L, Sun C (2022) SIRT1 attenuates neuroinflammation by deacetylating HSPA4 in a mouse model of Parkinson\u2019s disease. Biochim Biophys Acta Mol Basis Dis 1868:166365. https:\/\/doi.org\/10.1016\/j.bbadis.2022.166365","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"4088_CR165","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/postmj\/qgad080","volume":"100","author":"XY Yao","year":"2023","unstructured":"Yao XY, Guan LN, Chen Q, Ren C (2023) LRRK2 G2019S and Parkinson\u2019s disease: insight from neuroinflammation. Postgrad Med J 100:4\u201311. https:\/\/doi.org\/10.1093\/postmj\/qgad080","journal-title":"Postgrad Med J"},{"key":"4088_CR166","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.tox.2015.07.014","volume":"336","author":"J Zhang","year":"2015","unstructured":"Zhang J, Dai H, Deng Y, Tian J, Zhang C, Hu Z, Bing G, Zhao L (2015) Neonatal chlorpyrifos exposure induces loss of dopaminergic neurons in young adult rats. Toxicology 336:17\u201325. https:\/\/doi.org\/10.1016\/j.tox.2015.07.014","journal-title":"Toxicology"},{"key":"4088_CR167","doi-asserted-by":"publisher","first-page":"1428817","DOI":"10.1155\/2022\/1428817","volume":"2022","author":"L Zhang","year":"2022","unstructured":"Zhang L, Li C, Zhang Z, Zhang Z, Jin QQ, Li L, H\u00f6lscher C (2022a) DA5-CH and semaglutide protect against neurodegeneration and reduce \u03b1-synuclein levels in the 6-OHDA Parkinson\u2019s disease rat model. Parkinsons Dis 2022:1428817. https:\/\/doi.org\/10.1155\/2022\/1428817","journal-title":"Parkinsons Dis"},{"key":"4088_CR168","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.3390\/molecules25194359","volume":"25","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Zhou J, Shen M, Xu H, Yu S, Cheng Q, Ding F (2022b) Pyrroloquinoline quinone inhibits rotenone-induced microglia inflammation by enhancing autophagy. Molecules 25:4359. https:\/\/doi.org\/10.3390\/molecules25194359","journal-title":"Molecules"},{"key":"4088_CR169","doi-asserted-by":"publisher","first-page":"114630","DOI":"10.1016\/j.ecoenv.2023.114630","volume":"252","author":"H Zhang","year":"2023","unstructured":"Zhang H, Xie Z, Peng Y, Xie A, Fu C, Zheng D, Cai Z, Zhong J, Ming Q, Li M, Lu R, Liu X, Chen J (2023a) PARP1 promotes NLRP3 activation via blocking TFEB-mediated autophagy in rotenone-induced neurodegeneration. Ecotoxicol Environ Saf 252:114630. https:\/\/doi.org\/10.1016\/j.ecoenv.2023.114630","journal-title":"Ecotoxicol Environ Saf"},{"key":"4088_CR170","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00018-023-04807-7","volume":"80","author":"W Zhang","year":"2023","unstructured":"Zhang W, Ding L, Zhang M, Zheng S, Ma R, Gong J, Mao H, Xu H, Xu P, Zhang Y (2023b) Dietary intake of \u03b1-ketoglutarate ameliorates \u03b1-synuclein pathology in mouse models of Parkinson\u2019s disease. Cell Mol Life Sci 80:155. https:\/\/doi.org\/10.1007\/s00018-023-04807-7","journal-title":"Cell Mol Life Sci"},{"key":"4088_CR171","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1016\/j.apsb.2021.03.020","volume":"11","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Li F, Ning J, Peng R, Shang J, Liu H, Shang M, Bao XQ, Zhang D (2021a) Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4\/MyD88\/NF-\u03baB pathway through microbiota-gut-brain axis. Acta Pharm Sin B 11:2859\u20132879. https:\/\/doi.org\/10.1016\/j.apsb.2021.03.020","journal-title":"Acta Pharm Sin B"},{"key":"4088_CR172","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s40168-021-01107-9","volume":"9","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Ning J, Bao XQ, Shang M, Ma J, Li G, Zhang D (2021b) Fecal microbiota transplantation protects rotenone-induced Parkinson\u2019s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis. Microbiome 9:226. https:\/\/doi.org\/10.1186\/s40168-021-01107-9","journal-title":"Microbiome"},{"key":"4088_CR173","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2022.113369","volume":"168","author":"Q Zhou","year":"2022","unstructured":"Zhou Q, Zhang Y, Lu L, Zhang H, Zhao C, Pu Y, Yin L (2022) Copper induces microglia-mediated neuroinflammation through ROS\/NF-\u03baB pathway and mitophagy disorder. Food Chem Toxicol 168:113369. https:\/\/doi.org\/10.1016\/j.fct.2022.113369","journal-title":"Food Chem Toxicol"},{"key":"4088_CR174","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2023.153582","volume":"494","author":"Q Zhou","year":"2023","unstructured":"Zhou Q, Zhang Y, Lu L, Shi W, Zhang H, Qin W, Wang Y, Pu Y, Yin L (2023) Upregulation of postsynaptic cAMP\/PKA\/CREB signaling alleviates copper(II)-induced oxidative stress and pyroptosis in MN9D cells. Toxicology 494:153582. https:\/\/doi.org\/10.1016\/j.tox.2023.153582","journal-title":"Toxicology"},{"key":"4088_CR175","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.4103\/NRR.NRR-D-23-01684","volume":"20","author":"S Zhou","year":"2025","unstructured":"Zhou S, Li T, Zhang W, Wu J, Hong H, Quan W, Qiao X, Cui C, Qiao C, Zhao W, Shen Y (2025) The cGAS-STING-interferon regulatory factor 7 pathway regulates neuroinflammation in Parkinson\u2019s disease. Neural Regen Res 20:2361\u20132372. https:\/\/doi.org\/10.4103\/NRR.NRR-D-23-01684","journal-title":"Neural Regen Res"},{"key":"4088_CR176","doi-asserted-by":"publisher","first-page":"S183","DOI":"10.3233\/JPD-223277","volume":"12","author":"M Zimmermann","year":"2022","unstructured":"Zimmermann M, Brockmann K (2022) Blood and cerebrospinal fluid biomarkers of inflammation in Parkinson\u2019s disease. J Parkinsons Dis 12:S183\u2013S200. https:\/\/doi.org\/10.3233\/JPD-223277","journal-title":"J Parkinsons Dis"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-04088-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-025-04088-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-04088-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:42:41Z","timestamp":1756903361000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-025-04088-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":176,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["4088"],"URL":"https:\/\/doi.org\/10.1007\/s00204-025-04088-y","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]},"assertion":[{"value":"11 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}